We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FALABELLA:BCSFalabella S.A. Analysis

Data as of 2026-05-19 - not real-time

CLP 5,650.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Falabella is trading just above its 20‑day SMA and near the recent support level, yet remains beneath the 50‑day and 200‑day averages, underscoring a short‑term pullback within a longer‑term bearish backdrop. The 30‑day volatility of nearly 39 % signals a highly erratic price environment, while a beta of roughly 0.5 suggests the stock moves less than the market overall. Momentum indicators are mixed: the RSI hovers around the neutral 50 mark, and the MACD has turned bullish, with a small positive histogram, hinting at a potential short‑term rebound. Nevertheless, the price sits well above the discounted cash‑flow fair value of roughly 4,380 CLP, implying the market is pricing in optimism beyond intrinsic estimates. The current fear‑and‑greed reading of extreme greed reflects strong investor appetite, which may be inflating the valuation.
Fundamentally, Falabella delivers solid top‑line growth of about 7 % and healthy margins, while generating robust operating cash flow and free cash flow that comfortably cover its modest dividend payout of roughly 1.7 %. A payout ratio near 23 % and a dividend yield above the regional average point to a sustainable dividend profile. The company's debt‑to‑equity ratio is elevated, but the low leverage relative to earnings and ample cash reserves mitigate immediate solvency concerns. Given the overvalued technical stance but attractive dividend and steady cash generation, the stock leans toward a value‑oriented blend with moderate growth potential. Overall risk is tempered by low systematic beta but heightened by sector cyclicality, geographic concentration in Latin America, and elevated price volatility. We therefore recommend holding in the near term, maintaining a neutral stance in the medium horizon, and considering a gradual accumulation for long‑term investors who value dividend yield and cash flow stability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near support but below longer‑term averages
  • neutral RSI and bullish MACD hint at limited upside
  • high volatility and overvalued DCF

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • solid cash flow and dividend sustainability
  • elevated debt but manageable with strong liquidity
  • valuation still above intrinsic estimates

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • sustainable dividend yield
  • steady earnings growth and market position in Latin America
  • robust free cash flow supporting long‑term resilience

Key Metrics & Analysis

Financial Health

Revenue Growth6.90%
Profit Margin10.25%
P/E Ratio10.2
ROE21.55%
ROA3.73%
Debt/Equity55.08
P/B Ratio1.7
Op. Cash FlowCLP1432.0B
Free Cash FlowCLP849.8B

Technical Analysis

TrendBearish
RSI49.4
SupportCLP 5,237.70
ResistanceCLP 5,969.90
MA 20CLP 5,635.99
MA 50CLP 5,781.22
MA 200CLP 5,909.57
MACDBullish
VolumeIncreasing
Fear & Greed Index89.38

Valuation

Fair ValueCLP 4,381.82
Target PriceCLP 6,660.00
Upside/Downside17.88%
GradeOvervalued
TypeBlend
Dividend Yield1.74%

Risk Assessment

Beta0.53
Volatility38.63%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.